e-learning
resources
Paris 2018
Monday, 17.09.2018
Pleural effusions, infections and tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative results of Sericin pleurodesis, as a novel pleurodesis agent
A. Yazicioglu (Ankara, Turkey), S. Uysal (Zonguldak, Turkey), T. Sahinoglu (Konya, Turkey), M. Subasi (Ankara, Turkey), F. Demirag (Ankara, Turkey), E. Yekeler (Ankara, Turkey)
Source:
International Congress 2018 – Pleural effusions, infections and tumours
Session:
Pleural effusions, infections and tumours
Session type:
Thematic Poster
Number:
2572
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Yazicioglu (Ankara, Turkey), S. Uysal (Zonguldak, Turkey), T. Sahinoglu (Konya, Turkey), M. Subasi (Ankara, Turkey), F. Demirag (Ankara, Turkey), E. Yekeler (Ankara, Turkey). Comparative results of Sericin pleurodesis, as a novel pleurodesis agent. 2572
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Experimental pleurodesis using iodopovidone
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008
Combination is better than a single agent to create pleurodesis in rabbits
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005
Efficacy and safety of autologous blood pleurodesis versus talc pleurodesis in patients with malignant pleural effusions: Preliminary results
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Efficacy of thoracoscopic talc poudrage pleurodesis and predictive factors for its success in malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 72s
Year: 2005
Talc pleurodesis: talc slurry versus thoracoscopic talc poudrage
Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Year: 2008
VATS and laser pleurodesis is alternative method of treatment of nonspecific spontaneous pneumothorax
Source: Eur Respir J 2005; 26: Suppl. 49, 633s
Year: 2005
Safety and efficacy of pleurodesis with thoracoscopic doxycycline poudrage in malignant pleural effusion
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study
Source: Eur Respir J 2011; 38: 770-773
Year: 2011
Therapeutic local procedures: pleurodesis
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=311
Year: 2002
Iodopovidone: An effective agent pleurodesis used through chest tube
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
Success rate of talc pleurodesis
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Combination therapy with intrapleural doxycycline and talc in reduced doses for pleurodesis
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
Thoracoscopic pleurodesis with talc using local anesthesia
Source: Annual Congress 2007 - Interventional pneumology and surgical procedures
Year: 2007
The effect of corticosteroids on pleurodesis induced by iodopovidone in rabbits
Source: Eur Respir J 2006; 28: Suppl. 50, 650s
Year: 2006
Videothoracoscopy is effective for the management of pneumothorax recurrences after talc pleurodesis
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003
Talc pleurodesis: three important papers
Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Year: 2014
Safety of large-particle talc pleurodesis after talc poudrage under thoracoscopy for primary spontaneous pneumothorax. A European multicentre prospective study
Source: Annual Congress 2009 - Pleural problems, congenital lesions and novel technical devices
Year: 2009
Thoracoscopic talc poudrage
versus
povidone-iodine for pleurodesis of effusion due to metastatic breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006
Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax
Source: Eur Respir J 2007; 29: 757-760
Year: 2007
Intrapleural injection of talc and silver nitrate produce excellent pleurodesis in mice
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept